What Happened: ORDAN's recent move involves selling 23,000 shares of Pediatrix Medical Group. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on ...

Despite Henry Schein’s underperformance relative to its peers, Wall Street analysts remain moderately optimistic about the ...

PODD holds a Zacks Rank #2. For 2026, its revenues and EPS are expected to grow 19.8% and 26.3%, respectively. The company’s ...

The ASX Healthcare sector has finished the week of December 19, 2025 down 1.6% with few signs of a much needed Christmas ...

UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.

Elevance Health, Inc. (NYSE:ELV) is one of the best stocks to buy according to Seth Klarman. As of December 12, the average ...

Get the latest on Alcon's pending acquisition of LENSAR—deal updates, regulatory hurdles, and investment outlook.

Clover Health Investments CLOV is well poised for growth in the coming quarters, courtesy of its broad product spectrum. This ...

Nordson’s third quarter saw flat sales compared to the previous year, as the company navigated persistent softness in ...

The DMK may consider a two-tier campaign, where they keep the focus on Chief Minister Stalin, as a senior statesman with ...

In 2024 and 2025, the MedTech sector has operated against a backdrop of a global economy marked by slowing growth, moderating ...

Here is how Adma Biologics (ADMA) and Artivion (AORT) have performed compared to their sector so far this year.